Skip to main content

Advertisement

Log in

Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation

  • Case Report
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

We report the case of a 72 yr-old woman who underwent total thyroidectomy and resection of neck lymph nodes because of a firm nodule in the right lobe, which was consistent with medullary thyroid carcinoma (MTC) on cytological examination. Histology showed multifocal bilateral MTC; a 2 mm papillary thyroid carcinoma (PTC) was also detected in the right lobe, next to a focus of MTC; five cervical lymph nodes contained MTC. In one right perithyroidal lymph node, concurrent metastases of MTC and PTC were demonstated. DNA analysis showed a point mutation in exon 14 at codon 804 of the RET proto-oncogene locus, as frequently found in cases of familial MTC (FMTC).

To our knowledge, this case represents the first documented case of concurrent lymph node metastases of MTC and PTC in a patient with RET proto-oncogene germline mutation. We report this unique case, discuss related thyroid malignancies, and suggest possible underlying pathogenetic mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Heshmati HM, Gharib H, van Heerden, JA, Sizemore GW. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am J Med 103:60–69, 1997.

    Article  PubMed  CAS  Google Scholar 

  2. Murray, D. The thyroid gland. In: Kovasc, K., Asa S, eds. Functional endocrine pathology, vol. 1. Boston: Blackwell, pp. 293–374, 1991.

    Google Scholar 

  3. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET protoncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575–1579, 1996.

    Article  PubMed  CAS  Google Scholar 

  4. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911, 1989.

    Article  PubMed  CAS  Google Scholar 

  5. Lamberg BA, Reissel P, Stenman S, et al. Concurrent medullary and papillary thyroid carcinoma in the same thyroid lobe and in siblings. Acta Med Scand 209:421–424, 1981.

    Article  PubMed  CAS  Google Scholar 

  6. Albores-Saavedra J, de la Mora TG, Gould E. Mixed medullary-papillary carcinoma of the thyroid: apreviously unrecognized variant of thyroid gland. Hum Pathol 21:1151–1155, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Apel RL, Alpert LC, Rizzo A, LiVolsi V, Asa SL. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components. Arch Pathol Lab Med 118:1143–1147 1994.

    PubMed  CAS  Google Scholar 

  8. Matias-Guiu X, Caxas A, Costa I, Cadezas R, Prat J. Compound medullary-papillary carcinoma of the thyroid: true mixed tumour. Histopathology 25:183–185, 1994.

    Article  PubMed  CAS  Google Scholar 

  9. Pastolero GC, Coire CI, Asa SL. Concurrent medullary and papillary carcinomas of the thyroid with lymph node metastases. A collision phenomenon. Am J Surg Pathol 20:245–250, 1996.

    Article  PubMed  CAS  Google Scholar 

  10. Shimizu M, Hirokawa M, LiVolsi VA, et al. Combined “mixed medullary-follicular” and “papillary” carcinoma of the thyroid with lymph node metastasis. Endocr Pathol 11:353–358, 2000.

    Article  PubMed  Google Scholar 

  11. Shiroko T, Yokoo N, Okamoto K, et al. Mixed medullary-papillary carcinoma of the thyroid with lymph node metastases; report of a case. Surg Today 31:317–321, 2001.

    Article  PubMed  CAS  Google Scholar 

  12. Brauckhoff M, Gimm O, Hinze R, Ukkat J, Brauckhoff K, Dralle H, Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation. Thyroid 12:557–561, 2002.

    Article  PubMed  CAS  Google Scholar 

  13. Hales M, Rosenau W, Okerlund MD, Galante M. Carcinoma of the thyroid with a mixed medullary and follicular pattern. Morphologic, immunohistochemical, and clinical laboratory studies. Cancer 50:1352–1359, 1982.

    Article  PubMed  CAS  Google Scholar 

  14. Ljungberg O, Ericsson UB, Bodenson L, Thorell J. A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer 52:1053–1061, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. LiVolsi VA. Mixed thyroid carcinoma: a real entity? Lab Invest 57:237–239, 1987.

    PubMed  CAS  Google Scholar 

  16. Volante M, Papotti M, Roth J, et al. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499–1509, 1999.

    PubMed  CAS  Google Scholar 

  17. Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entiry. Lancet 353:637–639, 1999.

    Article  PubMed  CAS  Google Scholar 

  18. Fugazzola L, Cerutti N, Mannavola D, et al. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer. Clin Endocrinol (Oxf) 56:53–63, 2002.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Papi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papi, G., Corrado, S., Pomponi, M.G. et al. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation. Endocr Pathol 14, 269–276 (2003). https://doi.org/10.1007/s12022-003-0020-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-003-0020-4

Key Words

Navigation